Literature DB >> 24628797

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.

Peggy van der Pol1, Nienke Liebregts, Tibor Brunt, Jan van Amsterdam, Ron de Graaf, Dirk J Korf, Wim van den Brink, Margriet van Laar.   

Abstract

BACKGROUND AND AIMS: Increased delta-9-tetrahydrocannabinol (THC) concentrations in cannabis may lead to higher THC exposure, cannabis dependence and treatment need, but users may also adapt the actual intake of THC through reduced inhalation of THC containing smoke (titration). We investigated whether consumers of stronger cannabis use less cannabis per joint or inhale less smoke than those using less potent cannabis and whether these factors predict cannabis dependence severity.
METHODS: Heavy cannabis users (n = 98) brought their own cannabis, rolled a joint and smoked it ad libitum in a naturalistic setting. We analysed the content of the joint, its association with smoking behaviour and the cross-sectional and prospective (1.5-year follow-up) relations between smoking behaviour and cannabis dependence severity (total number of DSM-IV dependence symptoms).
RESULTS: THC concentration in cannabis (range 1.10-24.70%) was correlated positively with cannabis dose per joint (b = 0.008, P = 0.01), but the resulting THC concentration per joint (range 0.24-15.72%) was associated negatively with inhalation volume (b = -0.05, P = 0.03). Smoking behaviour measures (number of puffs, inhaled volume, reduction of puff volume and puff duration while smoking) predicted follow-up dependence severity, independently of baseline dependence severity and monthly THC dose (number of joints × cannabis dose × cannabis THC concentration). Monthly THC dose only predicted follow-up dependence severity when unadjusted for baseline severity.
CONCLUSIONS: Cannabis users titrate their delta-9-tetrahydrocannabinol intake by inhaling lower volumes of smoke when smoking strong joints, but this does not fully compensate for the higher cannabis doses per joint when using strong cannabis. Thus, users of more potent cannabis are generally exposed to more delta-9-tetrahydrocannabinol. Smoking behaviour appears to be a stronger predictor for cannabis dependence severity than monthly delta-9-tetrahydrocannabinol dose.
© 2014 Society for the Study of Addiction.

Entities:  

Keywords:  Dose; THC concentration; exposure; frequent cannabis use; marijuana; smoking topography; titration

Mesh:

Substances:

Year:  2014        PMID: 24628797     DOI: 10.1111/add.12508

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  34 in total

Review 1.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

2.  The potential impact of cannabis legalization on the development of cannabis use disorders.

Authors:  Alan J Budney; Jacob T Borodovsky
Journal:  Prev Med       Date:  2017-06-28       Impact factor: 4.018

3.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

Review 4.  Cannabinoids for Treatment of MS Symptoms: State of the Evidence.

Authors:  Jessica Rice; Michelle Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-19       Impact factor: 5.081

Review 5.  Changing landscape of cannabis: novel products, formulations, and methods of administration.

Authors:  Tory R Spindle; Marcel O Bonn-Miller; Ryan Vandrey
Journal:  Curr Opin Psychol       Date:  2019-04-09

6.  Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.

Authors:  Rosanna Smart; Jonathan P Caulkins; Beau Kilmer; Steven Davenport; Greg Midgette
Journal:  Addiction       Date:  2017-07-04       Impact factor: 6.526

Review 7.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

8.  Quantifying cannabis: A field study of marijuana quantity estimation.

Authors:  Mark A Prince; Bradley T Conner; Matthew R Pearson
Journal:  Psychol Addict Behav       Date:  2018-05-17

9.  Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013.

Authors:  Deborah S Hasin; Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Bridget F Grant
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596

10.  Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.

Authors:  Rachel L Tomko; Nathaniel L Baker; Erin A McClure; Susan C Sonne; Aimee L McRae-Clark; Brian J Sherman; Kevin M Gray
Journal:  Drug Alcohol Depend       Date:  2017-11-02       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.